Images
Contact
Report in La Vanguardia on how researchers go about discovering new compounds with therapeutic potential from the marine environment. The article makes reference a study performed by former IRB Barcelona researcher Mercedes Álvarez on baringolin, a molecule with antibiotic activity obtained from a marine microorganism off the coast of Alicante. Compounds of marine origin with biomedical interest arise due to the large number of diverse organisms that inhabit this ecosystem and the diversity of conditions to which they must adapt.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
